Tower 3.0 The most powerful Git client for Mac and Windows. Software Engineering. Developer Tools. Tower gives you access to Git’s powerful feature set. Tower comes with an extensive set of new features & reinvents existing ones from scratch. From Pull Requests to Interactive Rebase, it enables you to use Git. ROHN 25G Tower Sections are the world standard in galvanized steel tower. ROHN towers use double-bolted joints, which have been proven to be the best method of joining tower sections, for sturdiness and dependability. As a guyed structure, the standard 25G designs may rise to a height of 190 feet. ROHN 25G Tower Sections include the standard straight sections that are 10 feet in length. Click here?to get an answer to your question ️ A small telescope has an objective lens of focal length 150 cm and eyepiece of focal length 5 cm. What is the magnifying power of the telescope for viewing distant objects in normal adjustment?If this telescope is used to view a 100 m tall tower 3 km away, what is the height of the image of the tower formed by the objective lens? 1 The front headset connector supports CTIA style headsets and is re-taskable as a Line-in, Microphone-in, or Headphone-out port. Rear audio input ports are re-taskable as a Line-in or Microphone-in port. External speakers must be powered externally. Multi-streaming can be enabled in the audio control panel to allow independent audio streams to be sent to/from the front and rear jacks.
See also: Distance Matters | Effects By Power | SAR
The following precautionary guidelines are based on scientific research about biological and health effects at extremely low power densities. These are approximately 9000 times lower than international safety standards, whichare based on an outdated dogma maintaining that the only harm of microwaves lies in its thermal effects.Check the Table of Effects to see the levels at which various effects have been reported.
Year | Power Density Limit | Name | Description |
---|---|---|---|
2001 | 1,000μW/m2 | Salzburg Resolution | Equivalent of 1 mW/m2 = 0.1 μW/cm2 = 0.6 V/m ; The recommendation of Salzburg, Austria and now also organizations like BioInitiative and Next-Up. In 2008, Liechtenstein adopts the goal of 0.6 V/m, approximately 1000 μW/m2 by 2013. Proposed Limit for Public Exposure to Mobile Phone Base Stations |
2011 | 170 μW/m2 | Seletun Scientific Statement 2011 | Equivalent of 0.17 mW/m2 |
2001 | 100 μW/m2 | EU Parliament STOA 2001 | Equivalent of 100 nW/cm2 |
2002 | 10 μW/m2 | New Salzburg Precautionary Exposure Limit Outdoor | Equivalent of 10 μW/m2=0.06 V/m The recommendation for GSM 900/1800 mobile phone base stations updated by Salzburg Public Health; See also SBM 2008 below. Proposed Target for Personal Precaution |
2012 | 3-6 μW/m2 | Bioinitiative 2012 Recommendation | Equivalent of 0.3-0.6 nW/cm2 |
2002 | 1 μW/m2 | New Salzburg Precautionary Exposure Limit Indoor | Equivalent of 1 μW/m2=0.02 V/m Recommendation for indoor exposures, updated by Salzburg Public Health. Burgerforum 1999 & London Resolution of 2007 agree with the New Salzburg Exposure Limit. |
Click here to see what precautions other governments are recommending for wireless safety.
SBM 2008 (Standard of Building Biology Testing Methods) Guidelines for Sleeping Areas
No Concern | Slight Concern | Severe concern | Extreme concern |
---|---|---|---|
<0.1μW/m2 | 0.1μW/m2 to 10μW/m2 | 10μW/m2 to 1000μW/m2 | > 1000μW/m2 |
The Oberfranken study evaluated medical complaints of 356 people with long-term radiation in their homes. Above 100 microW/m2, only 5-6% of the people did not have adverse health effects. This is a level far below current safety standards.
Compare the radiation received from typical Wi-Fi routers and mobile phone base stations by applying the Inverse Square Law.
Now compare these precautionary guidelines with our current international safety standards for mobile phone base stations are dangerously out of date. The units below are provided in μW/m2. Check the conversion formulas if you need to convert the units to W/cm2 or V/m. Splayer 4 1 5 download free.
Year | Power Density Limit | Name | Description |
---|---|---|---|
1966 | 100,000,000 μW/m2 | ANSI C95.1 | Based on thermal effects |
1992 | 10,000,000 μW/m2 | ANSI/IEEE C95.1-1992 | Based on thermal effects, first recommended by IEEE ten years earlier in 1982. EPA calls it seriously flawed. |
1996 | 10,000,000 μW/m2 5,800,000 μW/m2 | FCC | USA: 5,800 mW/m2 averaged over a 30-minute period (869 MHz), previously recommended in 1986 by NCRP; 10,000 mW/m2 for PCS frequencies(1.85-1.99 GHz) |
1998 | 9,000,000 μW/m2 4,500,000 μW/m2 | ICNIRP | 9000 mW/m2 for 1800 MHz and 4,500 mW/m2 for 900 MHz. 4,500 mW/m2 is the equivalent of 61.0 V/m Prevalent standard |
Standards for personal wireless devices are also extremely high. For example:
- Microwave Ovens: The standard is 10,000,000μW/m2, or 1 mW/cm2, at a 5 cm distance, for FDA Guidelines for Microwave Ovens.
- Mobile Phones: For mobile phones, the standard in the USA is a SAR of 1.6 W/kg, based on behavioral disturbances observed in monkeys at 4 W/kg. However, harmful effects are seen in rat brains after only 2 hours of 0.2 W/kg exposure. See Mercola article on the flaws of the SAR standard, which is based on thermal health effects only.
In terms of power line magnetic fields, ICNIRP regulations allow for a generous AC (alternating current) magnetic field of 100,000 mG in Europe and 83,330 mG in North America.
Meanwhile, the Bioinitiative Working Group and Seletun Scientific Panel recommend exposures less than or equal to 1 milligauss, even though this, too, may turn out to be high. See factsheet on power lines.
SBM 2008 (Standard of Building Biology Testing Methods)
No Concern | Slight Concern | Severe concern | Extreme concern |
---|---|---|---|
<0.2 mG | 0.2 mG to 1 mG | 1 mG to 5 mG | > 5 mG |
Tower 3 6 0 Cm Berapa
As a reference point, Powerwatch notes that the average level in houses in the UK isTower 3 6 0 Cm =
0.5 milligauss. Nevertheless, I have definitely seen homes or apartments with higher levels than this.SBM 2008 (Standard of Building Biology Testing Methods)
No Concern | Slight Concern | Severe concern | Extreme concern |
---|---|---|---|
<10 mV | 10 to 100 mV | 100 to 1000 mV | > 1000 mV |
Further References
Kevin Seifert Named Chief Executive Officer of Nurse Assist
GREENWICH, Conn., July 18, 2018 – Tower Three Partners (“Tower Three”), a leading operationally-oriented private equity firm that invests in a concentrated portfolio of U.S.-based middle market companies, today announced that it has made a controlling investment in Nurse Assist, LLC (“Nurse Assist” or the “Company”), a privately-held, certified and FDA-registered manufacturer of medical devices and products that help improve the quality of care and life for patients. In connection with the investment, Kevin Seifert has assumed the role of Chief Executive Officer of Nurse Assist. Nurse Assist’s founder and previous CEO, Kevin Kile, will remain on the Company’s Board of Directors.
Founded in 1999 and headquartered in Haltom City, Texas, Nurse Assist is a fully-integrated medical device manufacturer focused on providing the highest quality of products and services to patients across the world. With superior quality, low-cost and consistent manufacturing capabilities, Nurse Assist has established itself as an innovative leader in the production of United States Pharmacopeia (USP) sterile water and normal saline. The Company’s products currently extend to four principal categories of medical devices, including USP water and saline and infusion care products, convenience kits, interconnecting cables and patient safety. With significant investment in automation and product development and an established platform in the dynamic and emerging pre-filled syringe market, the Company is well-positioned to meet the needs of its customers in the expanding senior population and continue on its trajectory of growth and strong performance.
Kevin Seifert, Chief Executive Officer of Nurse Assist, said, “As Nurse Assist continues to expand its operations and gain market share as a full-service provider of leading and trusted medical devices, including our USP sterile water and saline pre-filled syringe business, we will work aggressively to scale our business and expand distribution while leveraging our strong customer relationships and product development capabilities. With a loyal customer base, best-in-class manufacturing and an experienced management team, our fully-integrated business is uniquely positioned to capture the compelling infusion care product and patient care market opportunities ahead.”
Kevin Kile said, “We are thrilled to partner with Tower Three as Nurse Assist enters its next phase of growth servicing multiple high-volume, fast-growth markets. With automated production and in-house capabilities to maintain high capacity and quality, Nurse Assist is built on integrated manufacturing, from concept and design to validation and verification. I am confident our stakeholders – including customers, patients and employees – will benefit from Tower Three’s experience and expertise in helping companies broaden their infrastructure, strengthen operations and create greater scale as Nurse Assist continues to increase capacity and drive growth.”
William D. Forrest, Managing Partner of Tower Three, said, “We see enormous long-term potential in Nurse Assist and believe this is the ideal time to facilitate accelerated growth of a proven business. With this investment, Tower Three will leverage our deep operational experience and capital to help Nurse Assist build on its existing market position and further establish itself as a leading medical device provider. With Tower Three’s support, we are confident that Nurse Assist’s outstanding management team, led by Kevin Seifert, will capitalize on the Company’s tremendous market opportunities and continue to drive growth and profitability across the business.”
Terms of the transaction, which was completed in June 2018, were not disclosed.
About Kevin Seifert
Kevin Seifert is a leading innovator in the medical device industry with more than 20 years of operational experience in global healthcare. He most recently led Tower Three Medical, the healthcare-focused investment initiative of Tower Three Partners, and served on the Board of Directors of Facet Technologies, an FDA-certified engineering and manufacturing company specializing in the development of intuitive hand-held medical devices. Mr. Seifert previously served as Global President of Valleylab, Covidien’s electrosurgical platform, and Global President of Becton, Dickinson’s Consumer Healthcare
division, where he oversaw all global functions for diabetes products and ACE bandage products. Prior to that, he was President of Terumo Medical Care Products North America. Earlier in his career, he was the Vice President of Marketing and Sales and Investor Relations for Bio-Plexus Inc., a medical device manufacturer. Mr. Seifert received his Bachelors of Science degree in Marketing from University of Southern New Hampshire and holds multiple medical device patents.
About Tower Three Partners Tower Three Partners is a leading operationally-oriented private equity firm that invests in a concentrated portfolio of U.S.-based middle market companies. With long-term committed capital from major institutional investors and a senior management team that collectively has decades of experience revitalizing businesses, the firm targets equity investments of $50M to $150M that provide a catalyst for growth.
Tower Three Partners works collaboratively with the management teams of its portfolio companies to prioritize and implement transformative changes in operations, strategy, growth and/or capital structure to significantly improve business performance. Its professionals are experienced in operational improvement, revenue acceleration and mergers & acquisitions. The firm has invested in a range of businesses, including retail, consumer, healthcare, automotive and telecommunications.
For more information, visit our website at www.towerthreepartners.com or call 203-485-5800.
About Nurse Assist
Founded in 1999, Nurse Assist is a certified, FDA-registered manufacturer of medical devices and products that help improve the quality of care and life for patients. The company has established itself as a leader in the production of United States Pharmacopeia (USP) sterile water and normal saline, and its products extend to four principal categories of medical devices: USP water and saline and infusion care products, convenience kits, interconnecting cables and patient safety. Nurse Assist operates a fully-integrated, 131,200 square foot production facility at its headquarters in Haltom City, Texas.
For more information, visit our website at http://www.nurseassist.com/ or call 800-649-6800.
Muscular system 3d atlas of anatomy. Contacts
Tower Three Partners:
Postbox 3 0 5 – powerful and flexible email client. Loisann Poppo
203-485-5811
Media:
Jonathan Keehner / Aura Reinhard / Kate Clark
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449